magrolimab
Showing 1 - 15 of 15
MDS, Acute Myeloid Leukemia Trial (Sabatolimab, Magrolimab, Azacitidine)
Not yet recruiting
- Myelodysplastic Syndromes
- Acute Myeloid Leukemia
- Sabatolimab
- +2 more
- (no location specified)
May 24, 2022
Follicular Lymphoma, Marginal Zone Lymphoma, Mantle Cell Lymphoma Trial run by the NCI (Obinutuzumab, Venetoclax, Magrolimab)
Recruiting
- Follicular Lymphoma
- +4 more
- Obinutuzumab
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jul 20, 2022
Hodgkin Lymphoma, Classic Hodgkin Lymphoma, Relapsed Classical Hodgkin Lymphoma Trial in Stanford (Magrolimab, Pembrolizumab,
Recruiting
- Hodgkin Lymphoma
- +3 more
- Magrolimab
- +2 more
-
Stanford, CaliforniaStanford University
Jun 21, 2022
Metastatic Colorectal Cancer Trial in Duarte, St Leonards (Magrolimab, Bevacizumab, Irinotecan)
Recruiting
- Metastatic Colorectal Cancer
- Magrolimab
- +4 more
-
Duarte, California
- +1 more
Aug 4, 2022
Multiple Myeloma Trial in United States (Magrolimab, Daratumumab, Pomalidomide)
Recruiting
- Multiple Myeloma
- Magrolimab
- +5 more
-
Tucson, Arizona
- +8 more
Jul 28, 2022
Acute Myeloid Leukemia, Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Houston (Azacitidine,
Recruiting
- Acute Myeloid Leukemia
- +2 more
- Azacitidine
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Nov 16, 2021
Acute Myeloid Leukemia Trial in Worldwide (Magrolimab, Venetoclax, Azacitidine)
Recruiting
- Acute Myeloid Leukemia
- Magrolimab
- +3 more
-
Kansas City, Missouri
- +13 more
Aug 2, 2022
Myeloid Malignancies Trial in Australia, United Kingdom, United States (Magrolimab, Azacitidine, Venetoclax)
Recruiting
- Myeloid Malignancies
- Magrolimab
- +6 more
-
Birmingham, Alabama
- +12 more
Apr 6, 2022
Head and Neck Squamous Cell Carcinoma Trial in Worldwide (Magrolimab, Pembrolizumab, Docetaxel)
Recruiting
- Head and Neck Squamous Cell Carcinoma
- Magrolimab
- +6 more
-
Chandler, Arizona
- +31 more
Aug 16, 2022
Solid Tumor, Colorectal Cancer Trial in United States (Magrolimab, Cetuximab)
Completed
- Solid Tumor
- Colorectal Cancer
- Magrolimab
- Cetuximab
-
Los Angeles, California
- +7 more
Feb 8, 2021
Non Hodgkin Lymphoma Trial in Australia, United Kingdom, United States (Magrolimab, Rituximab, Gemcitabine)
Active, not recruiting
- Non Hodgkin Lymphoma
- Magrolimab
- +3 more
-
Birmingham, Alabama
- +19 more
Jun 8, 2022
Acute Myeloid Leukemia Trial in Worldwide (Magrolimab, Venetoclax, Azacitidine)
Active, not recruiting
- Acute Myeloid Leukemia
- Magrolimab
- +6 more
-
Duarte, California
- +25 more
Feb 4, 2022
MDS Trial in Worldwide (Magrolimab, Azacitidine, Placebo)
Recruiting
- Myelodysplastic Syndromes
- Magrolimab
- +2 more
-
Birmingham, Alabama
- +165 more
Aug 17, 2022